Literature DB >> 10090879

BRCA1 and BRCA2 testing: weighing the demand against the benefits.

P Devilee.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10090879      PMCID： PMC1377818          DOI： 10.1086/302350

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN： 0002-9297            Impact factor:   11.025


× No keyword cloud information.
  30 in total

1.  BRCA1--lots of mutations, lots of dilemmas.

Authors:  F S Collins
Journal:  N Engl J Med       Date:  1996-01-18       Impact factor: 91.245

2.  The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals.

Authors:  J P Struewing; D Abeliovich; T Peretz; N Avishai; M M Kaback; F S Collins; L C Brody
Journal:  Nat Genet       Date:  1995-10       Impact factor: 38.330

3.  Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locus.

Authors:  C M Phelan; T R Rebbeck; B L Weber; P Devilee; M H Ruttledge; H T Lynch; G M Lenoir; M R Stratton; D F Easton; B A Ponder; L Cannon-Albright; C Larsson; D E Goldgar; S A Narod
Journal:  Nat Genet       Date:  1996-03       Impact factor: 38.330

4.  Risk modifiers in carriers of BRCA1 mutations.

Authors:  S A Narod; D Goldgar; L Cannon-Albright; B Weber; R Moslehi; E Ives; G Lenoir; H Lynch
Journal:  Int J Cancer       Date:  1995-12-20       Impact factor: 7.396

5.  Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

Authors:  D F Easton; D Ford; D T Bishop
Journal:  Am J Hum Genet       Date:  1995-01       Impact factor: 11.025

6.  Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence.

Authors:  D Ford; D F Easton; J Peto
Journal:  Am J Hum Genet       Date:  1995-12       Impact factor: 11.025

7.  Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer.

Authors:  M G FitzGerald; D J MacDonald; M Krainer; I Hoover; E O'Neil; H Unsal; S Silva-Arrieto; D M Finkelstein; P Beer-Romero; C Englert; D C Sgroi; B L Smith; J W Younger; J E Garber; R B Duda; K A Mayzel; K J Isselbacher; S H Friend; D A Haber
Journal:  N Engl J Med       Date:  1996-01-18       Impact factor: 91.245

Review 8.  The search for the causes of breast and colon cancer.

Authors:  W Willett
Journal:  Nature       Date:  1989-03-30       Impact factor: 49.962

9.  Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

Authors:  D Ford; D F Easton; D T Bishop; S A Narod; D E Goldgar
Journal:  Lancet       Date:  1994-03-19       Impact factor: 79.321

10.  Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation.

Authors:  S A Gayther; W Warren; S Mazoyer; P A Russell; P A Harrington; M Chiano; S Seal; R Hamoudi; E J van Rensburg; A M Dunning; R Love; G Evans; D Easton; D Clayton; M R Stratton; B A Ponder
Journal:  Nat Genet       Date:  1995-12       Impact factor: 38.330
View more
  2 in total

1.  Prevalence of BRCA1 in a hospital-based population of Dutch breast cancer patients.

Authors:  H Papelard; G H de Bock; R van Eijk; T P Vliet Vlieland; C J Cornelisse; P Devilee; R A Tollenaar
Journal:  Br J Cancer       Date:  2000-09       Impact factor: 7.640

2.  Prevalence of BRCA1 and BRCA2 mutations in Korean breast cancer patients.

Authors:  Sei Hyun Ahn; Ui Kang Hwang; Beom Seok Kwak; Ho Sung Yoon; Bo Kyung Ku; Hee Jun Kang; Ji Su Kim; Byung Kyun Ko; Chang Dae Ko; Kyung Sik Yoon; Dae-Yeon Cho; Jun Suk Kim; Byung Ho Son
Journal:  J Korean Med Sci       Date:  2004-04       Impact factor: 2.153
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.